BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10024009)

  • 1. Caudate-putamen dopamine and stereotypy response profiles after intravenous and subcutaneous amphetamine.
    Cho AK; Melega WP; Kuczenski R; Segal DS; Schmitz DA
    Synapse; 1999 Feb; 31(2):125-33. PubMed ID: 10024009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular dopamine and amphetamine after systemic amphetamine administration: comparison to the behavioral response.
    Kuczenski R; Melega WP; Cho AK; Segal DS
    J Pharmacol Exp Ther; 1997 Aug; 282(2):591-6. PubMed ID: 9262319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization of amphetamine-induced stereotyped behaviors during the acute response.
    Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 1999 Feb; 288(2):699-709. PubMed ID: 9918578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.
    Clausing P; Gough B; Holson RR; Slikker W; Bowyer JF
    J Pharmacol Exp Ther; 1995 Aug; 274(2):614-21. PubMed ID: 7636721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.
    Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1997 Aug; 282(2):561-73. PubMed ID: 9262316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations.
    Florin SM; Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 1995 Jul; 274(1):231-41. PubMed ID: 7616403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of metaquant microdialysis for measurement of absolute concentrations of amphetamine and dopamine in brain: a viable method for assessing pharmacokinetic profile of drugs in the brain.
    Sood P; Cole S; Fraier D; Young AM
    J Neurosci Methods; 2009 Dec; 185(1):39-44. PubMed ID: 19747947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic "binge cocaine" on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice.
    Zhang Y; Schlussman SD; Ho A; Kreek MJ
    Synapse; 2003 Dec; 50(3):191-9. PubMed ID: 14515336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. l-methamphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived l-methamphetamine.
    Melega WP; Cho AK; Schmitz D; Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 1999 Feb; 288(2):752-8. PubMed ID: 9918585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate.
    Bowyer JF; Newport GD; Slikker W; Gough B; Ferguson SA; Tor-Agbidye J
    Toxicol Sci; 2000 May; 55(1):133-42. PubMed ID: 10788568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
    Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
    Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine-induced changes in behavior and caudate extracellular acetylcholine.
    Florin SM; Kuczenski R; Segal DS
    Brain Res; 1992 May; 581(1):53-8. PubMed ID: 1498671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
    Moroz IA; Peciña S; Schallert T; Stewart J
    Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated amphetamine treatment causes a persistent elevation of glial fibrillary acidic protein in the caudate-putamen.
    Armstrong V; Reichel CM; Doti JF; Crawford CA; McDougall SA
    Eur J Pharmacol; 2004 Mar; 488(1-3):111-5. PubMed ID: 15044042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral sensitization to amphetamine in rats: changes in the rhythm of head movements during focused stereotypies.
    Fowler SC; Birkestrand B; Chen R; Vorontsova E; Zarcone T
    Psychopharmacology (Berl); 2003 Nov; 170(2):167-77. PubMed ID: 12827349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration.
    Rivière GJ; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1042-7. PubMed ID: 10688621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term changes in dopamine-stimulated gene expression after single-day methamphetamine exposure.
    Belcher AM; O'Dell SJ; Marshall JF
    Synapse; 2009 May; 63(5):403-12. PubMed ID: 19177510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional variations in the physiology of the rat caudate-putamen. 1. In vivo subregional effects of amphetamine on extracellular dopamine concentration.
    Glynn G; Ahmad SO
    J Neural Transm (Vienna); 2003 May; 110(5):443-60. PubMed ID: 12721808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of brain temperature and caudate/putamen microdialysate levels of amphetamine and dopamine in rats after multiple doses of d-amphetamine.
    Clausing P; Bowyer JF
    Ann N Y Acad Sci; 1999; 890():495-504. PubMed ID: 10668455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics.
    Segal DS; Kuczenski R
    J Neurosci; 1997 Apr; 17(7):2551-66. PubMed ID: 9065515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.